Skip to content

Author

Yun-Hong Xu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Early disease control with a biochemical response to aumolertinib after postoperative recurrence of EGFR-Mutant stage IIIA lung adenocarcinoma after icotinib, with EGFR T790M detected at recurrence: a Case Report

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are a standard treatment for EGFR-mutant non-small cell lung cancer (NSCLC). However, acquired resistance commonly develops after treatment with first- or second-generation EGFR-TKIs. Aumolertinib, a third-generation EGFR-TKI, has demonstrated...

Zhen-Yu Niu, Ying-Juan-Jie Zhu, Yu Zhou et al. · 0 citations
Open access Aug 2026

Effects of different statin-based lipid-lowering therapies on stabilization and regression of carotid plaque: a randomized open-label trial

The combination of moderate-dose statins with PCSK9 inhibitors is significantly more effective than statin monotherapy or statin-ezetimibe combinations in stabilizing and regressing atherosclerotic carotid plaques in high-risk Asian populations.

Si-Hua Luo, Li-Li Lin, Yuhui Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.